Efficacy and Safety of Low-Dose (0.2 mg) Dutasteride for Male Androgenic Alopecia: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Phase III Clinical Trial. [PDF]
Lee S +13 more
europepmc +1 more source
Mechanism and clinical efficacy of peripheral blood alive cell treatment on androgenic alopecia. [PDF]
Zhao Z +6 more
europepmc +1 more source
Comparative study between fractional CO2 laser alone versus fractional CO2 laser combined with topical dutasteride in treatment of male androgenic alopecia. [PDF]
Galal SA, Ali MS, A HafizHala HS.
europepmc +1 more source
Does androgenic alopecia aggravate the risk of prostate cancer? Evidence from Mendelian randomization. [PDF]
Shi X +6 more
europepmc +1 more source
Stimulation of hair regrowth in an animal model of androgenic alopecia using 2-deoxy-D-ribose. [PDF]
Anjum MA +6 more
europepmc +1 more source
Causal Effects of Lipids-Related Metabolites on Androgenic Alopecia: A Mendelian Randomization Study. [PDF]
Bi L +7 more
europepmc +1 more source
Improvement of androgenic alopecia by extracellular vesicles secreted from hyaluronic acid-stimulated induced mesenchymal stem cells. [PDF]
Oh HG +12 more
europepmc +1 more source
CXCL12 Neutralizing Antibody Promotes Hair Growth in Androgenic Alopecia and Alopecia Areata. [PDF]
Zheng M +5 more
europepmc +1 more source
Identification of VLDL as a biomarker for prewarning of androgenic alopecia.
Shen Y +5 more
europepmc +1 more source

